Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pennwalt poison pill

Executive Summary

Dividend distribution plan creates one "preference" share purchase right on each outstanding share of common stock, with each right entitling shareholders to buy a fraction of a share of a new series of preference stock at an exercise price of $225. Rights will be exercisable only if a person or group acquires 20% or more of Pennwalt's stock or announces a tender offer.

Dividend distribution plan creates one "preference" share purchase right on each outstanding share of common stock, with each right entitling shareholders to buy a fraction of a share of a new series of preference stock at an exercise price of $225. Rights will be exercisable only if a person or group acquires 20% or more of Pennwalt's stock or announces a tender offer.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS012452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel